PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Blueprint Medicines Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 5,387,267 8.500% |
-863,556 (-13.82%) |
Filing |
| 2024-04-10 12:58 pm Purchase |
2024-03-31 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 6,250,823 10.200% |
815,206 (+15.00%) |
Filing |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 5,435,617 8.900% |
1,136,327 (+26.43%) |
Filing |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 4,299,290 7.200% |
-251,249 (-5.52%) |
Filing |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 4,550,539 7.700% |
862,773 (+23.40%) |
Filing |
| 2021-02-16 12:23 pm Purchase |
2020-12-31 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 3,687,766 6.600% |
334,199 (+9.97%) |
Filing |